ICD-10 Code R79.89: Other Specified Abnormal Blood Chemistry

Key Takeaways

ICD-10 Code R79.89 is a billable ICD-10-CM code for other specified abnormal findings of blood chemistry not captured by more specific codes.

R79.89 is the correct code for elevated troponin levels per AHA Coding Clinic 2019 Issue 2, not R77.9 or R74.8.

Documentation must identify the specific abnormal finding, the test performed, and clinical context – unspecified findings belong under R79.9, not R79.89.

Pabau’s claims management software helps practices track lab findings, attach supporting documentation, and reduce denials on abnormal chemistry codes.

Lab panels come back flagged every day. A troponin result sits above the reference range. A comprehensive metabolic panel shows a chemistry value with no clear category. The question for the coder is immediate: which ICD-10-CM code applies? When the abnormal finding is real, documented, and doesn’t fit a more specific category, ICD-10 Code R79.89 is the answer.

This guide covers everything clinicians and coders need to know about ICD-10 Code R79.89: its official definition, billable status, when to use it over related codes, documentation requirements, and the AHA Coding Clinic guidance that governs its most common application.

ICD-10 Code R79.89: Clinical Overview and Billable Status

ICD-10 Code R79.89 represents “Other specified abnormal findings of blood chemistry” within the ICD-10-CM classification system maintained by the CDC/NCHS. It belongs to category R79 (Other abnormal findings of blood chemistry), which sits inside the R70-R79 block covering abnormal findings on examination of blood without a definitive diagnosis.

The code is billable and specific. As of 2026, R79.89 is valid for reimbursement purposes and can be submitted as a standalone diagnosis code or as a secondary code alongside a confirmed condition. It covers abnormal blood chemistry results that are identified, documented, and clinically significant – but that don’t match the description of any other, more precise ICD-10-CM code in the R70-R79 range.

The code is maintained jointly by the Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS), in coordination with the World Health Organization’s broader ICD classification framework. Clinicians should note that R79.89 does not imply a definitive diagnosis – it documents the finding itself, not the underlying cause.

When to Use ICD-10 Code R79.89

R79.89 applies when blood chemistry testing returns an abnormal result that is clinically relevant and documented, but no more specific ICD-10-CM code accurately captures the finding. The operative phrase in the code description is “other specified” – the finding is identified and named, but it doesn’t fit the available specific categories within R79.

Use ICD-10 Code R79.89 in these clinical scenarios:

• Abnormal blood chemistry findings from a comprehensive metabolic panel (CMP) or basic metabolic panel (BMP) that don’t match the description of R79.83, R74.8, R77.9, or other specific codes in the R70-R79 range
• Elevated troponin levels without a confirmed cardiac diagnosis (see AHA Coding Clinic guidance below)
• Abnormal findings on antenatal screening of the mother that involve blood chemistry and don’t fit more specific codes
• Miscellaneous enzyme elevations or chemistry panel abnormalities identified during routine workup that require further investigation
• Combination coding scenarios where R79.89 serves as a secondary code alongside a confirmed primary diagnosis

ICD-10 Code R79.89 for Elevated Troponin: AHA Coding Clinic Guidance

The most clinically significant use case for ICD-10 Code R79.89 involves elevated troponin levels. This is where coding errors are most frequent, because several codes in the R70-R79 range appear superficially applicable.

Per AHA Coding Clinic 2019, Issue 2, coders should assign R79.89 for an elevated troponin level when no confirmed cardiac diagnosis exists. The guidance specifically states that R77.9 (Abnormal plasma protein, unspecified) and R74.8 (Abnormal levels of other serum enzymes) are not appropriate for troponin, because troponin is not technically classified as a plasma protein or a serum enzyme in the conventional sense. Assigning either of those codes would constitute miscoding and may trigger a denial or audit flag.

Practices using Pabau’s claims management software can flag elevated troponin lab results during documentation review, helping coders identify the correct R79.89 assignment before a claim is submitted.

ICD-10 Code R79.89 in Antenatal Screening Context

A less frequently discussed but valid application of ICD-10 Code R79.89 is for abnormal blood chemistry findings identified during antenatal screening of the mother. When routine maternal bloodwork returns a flagged chemistry value that is documented as clinically significant but doesn’t correspond to a more specific diagnostic code, R79.89 may apply. Coders should review the full ICD-10-CM index under “Screening, antenatal” to confirm the most precise coding path for the specific finding before defaulting to R79.89.

ICD-10 Code R79.89 Documentation Requirements

Supporting documentation is the difference between a clean claim and a denial. Because R79.89 sits in the “signs, symptoms, and abnormal laboratory findings” chapter of ICD-10-CM, payers will scrutinize whether the clinical record justifies its use.

The documentation must establish three things clearly:

1. The specific abnormal finding. Name the analyte or test result that was abnormal (e.g., “elevated troponin,” “abnormal CMP result – elevated BUN”). Generic references to “abnormal labs” are insufficient.
2. The test performed. Reference the laboratory order: the comprehensive metabolic panel, basic metabolic panel, or specific chemistry test that produced the finding. This establishes the clinical basis for the code.
3. Clinical relevance. The note must indicate that the finding was reviewed, that it is clinically significant, and either that a diagnosis is being pursued or that the finding is the reason for the encounter. Incidental findings not addressed in the encounter should not be coded.

Documentation checklists for clinical documentation workflows can support coders in capturing these elements consistently before the claim is generated. Structured templates that prompt providers to name specific lab abnormalities reduce the ambiguity that causes R79.89 claims to be challenged.

ICD-10 Code R79.89 vs Related Codes: Choosing Correctly

The R79 category contains several codes that look similar at first glance. Selecting the wrong one is a common source of both denials and audit exposure. Here is how ICD-10 Code R79.89 differs from its closest neighbors.

R79.89 vs R79.9: Specified vs Unspecified

R79.9 covers “Abnormal finding of blood chemistry, unspecified.” The critical difference is the word “specified” in R79.89. If the abnormal finding is named and documented – the coder knows exactly which analyte or chemistry result is flagged – R79.89 is the correct choice. R79.9 applies only when the documentation does not identify which blood chemistry finding was abnormal, or when the specific nature of the abnormality cannot be determined from the record. Payers and CMS guidance both favor specificity; defaulting to R79.9 when R79.89 is supportable may be viewed as under-coding.

R79.89 vs R74.8: Enzyme Elevations

R74.8 captures “Abnormal levels of other serum enzymes.” For most enzyme elevations – elevated ALT, AST, or alkaline phosphatase – R74.8 is appropriate. However, for troponin specifically, the AHA Coding Clinic 2019 Issue 2 guidance overrides this. Troponin is not appropriately classified as a serum enzyme for coding purposes under current guidance, so R74.8 should not be used for elevated troponin.

R79.89 vs R79.83: Amino Acid Levels

R79.83 specifically addresses “Abnormal findings of blood amino-acid level.” If the abnormal blood chemistry finding involves amino acid concentrations – such as elevated homocysteine or phenylalanine – R79.83 is the correct code, not R79.89. Use R79.89 only when the finding doesn’t fit R79.83 or any other specific code in the category.

Struggling to keep lab findings and diagnosis codes aligned?

Pabau's practice management platform helps healthcare teams document abnormal lab results, attach supporting notes, and submit accurate claims – so R79.89 and related codes are supported by the right documentation every time.

Book a demo

ICD-10 Code R79.89 Billing, Reimbursement, and Coding Pitfalls

Because R79.89 is a symptom/finding code rather than a definitive diagnosis code, its reimbursement profile requires careful attention. Payers’ behavior around this code varies, but several consistent patterns emerge across practice billing contexts.

Using ICD-10 Code R79.89 as a Primary vs Secondary Diagnosis

ICD-10 Code R79.89 can be used as a primary diagnosis code when the abnormal blood chemistry finding is the principal reason for the encounter and no confirmed diagnosis has been established. This is common in outpatient evaluation settings where a flagged lab result prompts a follow-up visit.

R79.89 also functions as a secondary code – attached to a primary diagnosis – when the abnormal chemistry finding is a complicating or comorbid factor. For example, a patient presenting with chest pain (primary code) who also has elevated troponin without confirmed myocardial infarction may carry R79.89 as a secondary finding code. Coders using lab management workflows integrated with the clinical record can streamline this dual-code assignment process.

Common Denial Reasons for R79.89 Claims

Several billing errors increase the likelihood of denial when submitting claims with R79.89. Understanding these patterns helps practices prevent them before claims leave the billing queue.

• Using R79.89 when a more specific code exists: If the chemistry finding does fit a specific code (e.g., R79.83 for an amino acid abnormality), bypassing that code in favor of R79.89 can trigger a denial for incorrect specificity.
• Using R79.89 without a documented finding: Payers expect the medical record to name the specific abnormality. “Abnormal lab panel” without identifying the analyte won’t support R79.89.
• Pairing R79.89 with a confirmed diagnosis that already explains the finding: Once a definitive diagnosis is established (e.g., acute MI confirmed), the sign/finding code R79.89 for elevated troponin should generally be dropped in favor of the confirmed diagnosis code. Coding both creates a sequencing conflict.
• Assigning R79.89 for troponin alongside R77.9 or R74.8: Per the AHA Coding Clinic, this constitutes miscoding and may flag the claim for audit review.

Practices that standardize their compliance management workflows can build pre-submission claim checks that catch these patterns before a denial is issued. The key is linking the coded diagnosis back to a specific lab result in the clinical record every time R79.89 appears on a claim.

ICD-9-CM to ICD-10-CM Conversion for R79.89

Practices managing older records or cross-referencing historical data may need to convert ICD-9-CM codes to ICD-10-CM. Using CMS General Equivalence Mappings (GEMs), ICD-10-CM R79.89 maps approximately to:

• 790.6 – Other abnormal blood chemistry (primary GEM match)
• 790.99 – Other nonspecific findings on examination of blood (alternate GEM mapping)

GEM mappings are approximate, not exact. The reverse mapping (ICD-9 to ICD-10) is also inexact, and a single ICD-9 code may map to multiple ICD-10-CM codes. Always review clinical documentation rather than relying solely on the GEM crosswalk when converting historical claims. The WHO’s ICD classification framework and CMS guidance take precedence over crosswalk approximations when a conflict arises.

R79.89 Coding Guidelines: Key Rules from CMS and AHA

The ICD-10-CM Official Guidelines for Coding and Reporting, published annually by CMS and NCHS, govern how R79.89 is applied. Several specific rules apply to symptom and finding codes in the R chapter.

• Do not code signs and symptoms with confirmed diagnoses: When a definitive diagnosis has been confirmed that routinely produces the abnormal blood chemistry finding, code only the confirmed diagnosis. R79.89 is appropriate during the evaluation period, before confirmation.
• Code the condition, not the test: R79.89 documents the abnormal finding, not the act of performing the blood test. The laboratory procedure codes (CPT) handle the test itself.
• Outpatient vs inpatient distinction: In outpatient settings, code to the highest degree of certainty at the time of the encounter. If the workup is ongoing, R79.89 is appropriate until a definitive diagnosis is reached. In inpatient settings, coders have more latitude to query providers and may wait for final confirmation before assigning a diagnosis code.
• Sequencing for combination coding: When R79.89 is used as a secondary code, it should follow the primary condition in claim sequencing. Misordering codes can affect DRG assignment in inpatient settings and reimbursement calculation in complex outpatient encounters.

For practices managing complex laboratory workflows across multiple providers, having clear coding policies for R79.89 – documented in a coding reference guide and accessible through the patient record system – reduces the variability that leads to inconsistent code assignment across the clinical team. Reviewed against current CMS ICD-10-CM Official Guidelines for Coding and Reporting and AHA Coding Clinic guidance.

Expert Picks

Need to document abnormal lab findings more precisely? Pabau’s Lab Management Software helps practices track ordered tests, flag abnormal results, and connect findings to the correct patient record for coding review.

Looking for related diagnostic code guidance? ICD-10 Code for Autistic Disorder provides a comparable walkthrough of ICD-10-CM code selection, documentation requirements, and coding pitfalls.

Managing claims for abnormal findings across multiple providers? Pabau’s Claims Management Software supports accurate code submission with documentation linking, reducing denial rates on abnormal chemistry codes.

Conclusion

Abnormal blood chemistry findings that don’t fit a precise ICD-10-CM category create real coding risk. Using the wrong code – R77.9 for troponin, R74.8 for an enzyme that doesn’t technically qualify, or the unspecified R79.9 when the finding is clearly named – opens claims to denial and audit scrutiny.

Pabau’s claims management software helps practices connect lab findings to the correct diagnosis code at the point of documentation – so R79.89 appears on claims with the supporting clinical detail payers require. To see how Pabau supports accurate diagnostic coding workflows across your practice, book a demo and speak with a specialist.

Frequently Asked Questions